HYE MIN YANG: Open Payments
NPI 1447839857 · GARDEN CITY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,016 in 45 payments from 12 companies in 2025. Trend: 2023 $1,028 · 2024 $1,173 · 2025 $1,016
Food & beverage: $1,016
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $245 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $180 |
| Xeris Pharmaceuticals, Inc. | 7 | $161 |
| Medtronic, Inc. | 9 | $139 |
| Amneal Pharmaceuticals LLC | 3 | $81 |
| Ascendis Pharma Endocrinology Inc | 2 | $48 |
| Lilly USA, LLC | 2 | $48 |
| KYOWA KIRIN, INC. | 1 | $27 |
| RECORDATI_RARE_DISEASES_INC. | 1 | $24 |
| Rhythm Pharmaceuticals, Inc. | 1 | $22 |
Products named: JARDIANCE, RECORLEV, MINIMED 780G, Ozempic, UNITHROID, Wegovy, Rybelsus, Yorvipath.
Industry payments across NY — which companies pay providers there.
